SCHEMBL21671894

SCHEMBL21671894

CN1Cc2ccc(N)cc2C2(CC2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.47
MAPT P10636 2/20 0.36
RAD52 P43351 1/20 0.36
DRD1 P21728 1/20 0.35
OPRD1 P41143 4/20 0.35
OPRK1 P41145 2/20 0.35
OPRM1 P35372 1/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
ADRA2C P18825 2/20 0.35
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
GFER P55789 1/20 0.34
KMT2A Q03164 1/20 0.34
PTK2B Q14289 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1558847 0.88 KDM4E (0.46) KDM4EMAPTRAD52DRD1ADRA2C
SCHEMBL30561532 0.88 KDM4E (0.46) KDM4EMAPTRAD52DRD1ADRA2C
Hydrochloric Acid SCHEMBL1557318 0.87 KDM4E (0.48) KDM4EMAPTRAD52DRD1ADRA2C
SCHEMBL21641752 0.82 CYP2D6 (0.33) KDM4EOPRD1OPRK1OPRM1GRIN2D
SCHEMBL24124011 0.81 KDM4E (0.48) KDM4EGRIN1GRIN2AMAOAMAOB
SCHEMBL25932938 0.79 KDM4E (0.47) KDM4EDRD1OPRD1OPRK1OPRM1
SCHEMBL25675778 0.77 KDM4E (0.44) KDM4EDRD1ALDH1A1MAOAMAOB
SCHEMBL26408039 0.77 KDM4E (0.44) KDM4EDRD1ALDH1A1DRD2HTR2A
SCHEMBL17383970 0.77 MAOA (0.48) KDM4EDRD1MAOAMAOBDRD2
SCHEMBL29391669 0.77 MAOA (0.48) KDM4EDRD1MAOAMAOBDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3604306-A1 MACROCYCLIC DERIVATIVE OF PYRAZOL[3,4-D]PYRIMIDIN-3-ONE, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai de Novo Pharmatech Co., Ltd. (CN) 2020-02-05 EP disclosed